(RTTNews) - Calyxt, Inc. (CLXT), a plant-based synthetic biology company, and Cibus, a leader in precision gene editing in agriculture, announced Tuesday that both companies have entered into a ...
A Minnesota food genetics company that signed a 20-year sale-leaseback days before construction started on its Roseville headquarters in 2017 now has its second landlord in two years. Fremont-based ...
ROSEVILLE, Minn., Jan. 6, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced that its pilot BioFactory™ production system, installed in ...
NEW BRIGHTON, Minn. (AP) _ Calyxt Inc. (CLXT) on Wednesday reported a loss of $7.6 million in its second quarter. The New Brighton, Minnesota-based company said it had a loss of 25 cents per share.
Calyxt Inc., a New Brighton-based agriculture company aimed at designing healthier foods using gene-editing technology developed by the University of Minnesota, kicks off its initial public offering ...
ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced the appointment of current board member Yves Ribeill, Ph.D., as Chairman. This appointment ...
On January 17, 2023, Calyxt announced it had entered into a definitive merger agreement with Cibus Global, LLC (Cibus), a leader in precision gene editing in agriculture, under which Calyxt and Cibus ...
Calyxt, a food technology company spawned by the University of Minnesota, said this week it will offer its gene-editing technology in licensing deals to other companies. The company — whose technology ...
Calyxt has put all the pieces in place to commercialize its gene-edited high-oleic soybean oil, but still needs commercial buyers to sign up. Once commercialization begins, Calyxt will need to manage ...
Plant-based technology company Calyxt boosted revenue significantly in 2019, but still ended the year with a significant net loss, according to a year-end report released Thursday. Executives for the ...
ROSEVILLE, MINN. — Calyxt, Inc. achieved a milestone in 2019 when high-oleic soybeans became the company’s first commercially available gene-edited product in the United States through the company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results